Home › Funds › Ilex Capital Partners (UK) LLP › RMD

Ilex Capital Partners (UK) LLP position in RMD

RESMED INC · Health Care

Ilex Capital Partners (UK) LLP reported holding 737,472 shares of RMD (RESMED INC) in its Q3 2026 13F filing — a position valued at US$163.1M, representing 3.16% of its reported portfolio and ranking #9 among its reported holdings. Ilex Capital Partners (UK) LLP has disclosed RMD holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)737.47K sh
Reported value held$163.06M
Portfolio Weight3.16%
First reportedQ2 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ilex Capital Partners (UK) LLP's RMD position evolved

Ilex Capital Partners (UK) LLP first disclosed a stake in RMD in Q2 2025 at 152,347 shares (US$39.3M). The position peaked in Q3 2026 at 737,472 shares, worth US$163.1M. Across 6 filings, Ilex Capital Partners (UK) LLP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 737,472 shares valued at US$163.1M — an increase of 381,718 shares quarter over quarter.. Notable position changes include a 165% increase in Q4 2025 (shares fell 7% over the following quarter), a 68% increase in Q1 2026 (shares fell 13% over the following quarter), a 107% increase in Q3 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 152.35K $39.31M New
Q3 2025 92.89K $25.43M Reduce
Q4 2025 246.01K $59.26M Add
Q1 2026 413.86K $92.90M Add
Q2 2026 355.75K $69.33M Reduce
Q3 2026 737.47K $163.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RMD and 13F data

RMD (RESMED INC) is a Health Care company. 30 other funds we track also report a position in RMD. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RMD

No other tracked fund reports a position in RMD.

All RMD fund holders →

FAQ

How long has Ilex Capital Partners (UK) LLP held RMD?

Ilex Capital Partners (UK) LLP has disclosed RMD holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Ilex Capital Partners (UK) LLP's current position in RMD?

As of Q3 2026, Ilex Capital Partners (UK) LLP holds 737.47K shares of RMD (RESMED INC), valued at $163.06M, representing 3.16% of its reported portfolio and ranking #9.

Has Ilex Capital Partners (UK) LLP been buying or selling RMD?

In the latest 13F filing (Q3 2026), Ilex Capital Partners (UK) LLP increased its position in RMD. The position peaked in Q3 2026 at 737.47K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.